Biotheus’ Bifunctional Therapeutic PM8001 has been Approved by the USFDA to Enter Phase II Studies

PR Newswire
December 3, 2021 — 16:23 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: biotech China chinese guangdong United States

Related News:

Lianlian Global Showcases Latest Innovations at Money 20/20 Asia 2024

April 25, 2024 — 23:52

Terra Drone, Unifly, and Aloft Technologies Launch UTM Development for AAM Targeting Global Markets

April 25, 2024 — 07:00

Tantech Holdings Ltd Announces $2.1 Million Private Placement

April 23, 2024 — 03:58

GT20029 China Phase II Trial For AGA Reached Primary Endpoint

April 22, 2024 — 09:53

ASTRI’s Wins 23 Awards Geneva Inventions Expo

April 20, 2024 — 16:31

Inaugural ‘Korea Medical Innovation Research Forum’ regular seminar, a success

April 19, 2024 — 21:00

Automation Anywhere Earns 2024 Great Place To Work Certification™

April 18, 2024 — 22:00

St. Joseph’s Children’s Hospital Foundation Receives Historic $50 Million Gift from the Pagidipati Family of Tampa

April 11, 2024 — 09:18

Tsingke Showcases Cutting-Edge Biologics Solutions at Biologics 2024

April 10, 2024 — 14:19